Terms: = Lymphoma AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Prognosis
194 results:
1. Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Nabergoj M; Eikema DJ; Koster L; Platzbecker U; Sockel K; Finke J; Kröger N; Forcade E; Nagler A; Eder M; Tischer J; Broers AEC; Kuball J; Wilson KMO; Hunault-Berger M; Collin M; Russo D; Corral LL; Helbig G; Mussetti A; Scheid C; Gurnari C; Raj K; Drozd-Sokolowska J; Yakoub-Agha I; Robin M; McLornan DP
Bone Marrow Transplant; 2024 Mar; 59(3):395-402. PubMed ID: 38195984
[TBL] [Abstract] [Full Text] [Related]
2. When to use which molecular prognostic scoring system in the management of patients with mds?
Kewan T; Bewersdorf JP; Gurnari C; Xie Z; Stahl M; Zeidan AM
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101517. PubMed ID: 38092484
[TBL] [Abstract] [Full Text] [Related]
3. Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes.
Zhao Y; Guo J; Zhao S; Wang R; Wu D; Chang C
Leuk Lymphoma; 2024 Jan; 65(1):100-108. PubMed ID: 37865969
[TBL] [Abstract] [Full Text] [Related]
4. Role of IL8 in myeloid malignancies.
Ramachandra N; Gupta M; Schwartz L; Todorova T; Shastri A; Will B; Steidl U; Verma A
Leuk Lymphoma; 2023; 64(11):1742-1751. PubMed ID: 37467070
[TBL] [Abstract] [Full Text] [Related]
5. CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
[TBL] [Abstract] [Full Text] [Related]
6. Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment.
Bewersdorf JP; Xie Z; Zeidan AM
Cancer J; 2023 May-Jun 01; 29(3):195-202. PubMed ID: 37195776
[TBL] [Abstract] [Full Text] [Related]
7. Wilms' tumor 1 expression combined with genetic mutations for prognostic assessment in mds.
Pan D; Zhao W; Jiang Q; Yin C; He H; Liao L; Ye J; Dai M
Leuk Lymphoma; 2023 Apr; 64(4):856-864. PubMed ID: 36905177
[TBL] [Abstract] [Full Text] [Related]
8. Molecular landscape of myelodysplastic neoplasms in disease classification and prognostication.
Maggioni G; Della Porta MG
Curr Opin Hematol; 2023 Mar; 30(2):30-37. PubMed ID: 36728601
[TBL] [Abstract] [Full Text] [Related]
9. [Efficacy and safety of Venetoclax in the treatment of 25 patients with recurrent hematologic malignancies after an allogeneic hematopoietic stem cell transplantation].
Chen X; Liu ZY; Zhang RL; Zhai WH; Ma QL; Pang AM; Yang DL; He Y; Wei JL; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):542-549. PubMed ID: 36709130
[No Abstract] [Full Text] [Related]
10. A Pediatric Case of Treatment-related Myelodysplastic Syndrome While on Therapy for Pre-B Acute Lymphoblastic Leukemia.
McElroy S; Myers GD; Flatt T
J Pediatr Hematol Oncol; 2023 May; 45(4):e518-e521. PubMed ID: 36706304
[TBL] [Abstract] [Full Text] [Related]
11. Providing Care to People Living with a Chronic Hematological Malignancy: A Qualitative Evidence Synthesis of Informal Carers' Experiences.
Cormican O; Dowling M
Semin Oncol Nurs; 2022 Dec; 38(6):151338. PubMed ID: 36270864
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
[TBL] [Abstract] [Full Text] [Related]
13. SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome.
Falantes JF; Márquez-Malaver FJ; Carrillo E; Culebras MG; Morales R; Prats C; Vargas MT; Caballero T; Rodríguez-Arbolí E; Espigado I; Pérez-Simón JA
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):e1059-e1066. PubMed ID: 36117041
[TBL] [Abstract] [Full Text] [Related]
14. A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the mds-CAN registry.
Buckstein R; Chodirker L; Mozessohn L; Yee KWL; Geddes M; Zhu N; Shamy A; Leitch HA; Christou G; Banerji V; Brian L; Khalaf D; St-Hilaire E; Finn N; Nevill T; Keating MM; Storring J; Delage R; Parmentier A; Thambipillai A; Siddiqui M; Westcott C; Cameron C; Mamedov A; Spin P; Tang D
Leuk Lymphoma; 2022 Dec; 63(13):3165-3174. PubMed ID: 36095125
[TBL] [Abstract] [Full Text] [Related]
15. SOHO State of the Art and Next Questions: Treatment of Higher-Risk Myelodysplastic Syndromes.
Aubrey BJ; Brunner AM
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):869-877. PubMed ID: 36030175
[TBL] [Abstract] [Full Text] [Related]
16. Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome.
Lyu X; Li T; Zhu D; Cheng Y; Chen Y; He X; Li Z; Li S; Wu W; Geng S; Zhang M; Yao C; Li J; Li Y; Chang Y; Li Y; Zhu Z; Mao M; Song Y
Leuk Lymphoma; 2022 Oct; 63(10):2301-2310. PubMed ID: 35695096
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic role of controlling nutritional status score in hematological malignancies.
Zhang Y; Chen Q; Lu C; Yu L
Hematology; 2022 Dec; 27(1):653-658. PubMed ID: 35622088
[TBL] [Abstract] [Full Text] [Related]
18. Predictive and prognostic value of gene mutations in myelodysplastic syndrome treated with hypomethylating agents: a meta-analysis.
Hu C; Wang X
Leuk Lymphoma; 2022 Oct; 63(10):2336-2351. PubMed ID: 35543621
[TBL] [Abstract] [Full Text] [Related]
19. Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and lymphoma Group (ALLG) consensus statement.
Enjeti AK; Agarwal R; Blombery P; Chee L; Chua CC; Grigg A; Hamad N; Iland H; Lane S; Perkins A; Singhal D; Tate C; Tiong IS; Ross DM
Pathology; 2022 Jun; 54(4):389-398. PubMed ID: 35461716
[TBL] [Abstract] [Full Text] [Related]
20. t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies.
Bernués M; González T; Corchete LA; Santos S; Durán MA; López-Andrade B; Riso LL; Martínez-Serra J; Ramos R; Iglesias J; Royo I; Rosell J
Cancer Genet; 2022 Jun; 264-265():60-65. PubMed ID: 35397254
[TBL] [Abstract] [Full Text] [Related]
[Next]
